Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Carcinoma (RCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06127238
What this trial is testing

Study of ST-1898 in Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma
Beijing Scitech-Mq Pharmaceuticals Limited 90
Testing effectiveness (Phase 2)Study completedNCT03463681
What this trial is testing

CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT04074967
What this trial is testing

Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab

Who this might be right for
Renal Cell CarcinomaMelanomaSolid Tumor+2 more
Dan Zandberg 70
Early research (Phase 1)Study completedNCT02387307
What this trial is testing

RSIFN-co in Subjects With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma+2 more
Sichuan Huiyang Life Science and Technology Corporation 42
Early research (Phase 1)Looking for participantsNCT05518253
What this trial is testing

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Weijia Fang, MD 30
Early research (Phase 1)Study completedNCT00199875
What this trial is testing

Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250

Who this might be right for
Renal Cell CarcinomaKidney NeoplasmRenal Cancer+1 more
Ludwig Institute for Cancer Research 18
Testing effectiveness (Phase 2)Study completedNCT04704219
What this trial is testing

Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 160
Not applicableEnded earlyNCT02071719
What this trial is testing

Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients

Who this might be right for
Renal Cell Cancer
M. Labots 6
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Not Yet RecruitingNCT07770802
What this trial is testing

Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer

Who this might be right for
Clear Cell Renal Cell Carcinoma
Qingdao Sino-Cell Biomedicine Co., Ltd. 15
Large-scale testing (Phase 3)Active Not RecruitingNCT03873402
What this trial is testing

Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 437
Large-scale testing (Phase 3)Looking for participantsNCT07383441
What this trial is testing

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
SWOG Cancer Research Network 718
Early research (Phase 1)Looking for participantsNCT06582017
What this trial is testing

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Who this might be right for
Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more
Nammi Therapeutics Inc 100
Early research (Phase 1)Ended earlyNCT04895748
What this trial is testing

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Looking for participantsNCT07636785
What this trial is testing

And 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more
VM Discovery, Inc. 111
Not applicableNot Yet RecruitingNCT07776483
What this trial is testing

Personalized ctDNA Monitoring for Predicting Immunotherapy Outcomes in Advanced Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Non-Clear Cell Renal Cell Carcinoma
West China Hospital 67
Not applicableNot Yet RecruitingNCT07500831
What this trial is testing

Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellMetastatic Renal Cell CarcinomaAdvanced Renal Cell Carcinoma
Qilu Hospital of Shandong University 43
Early research (Phase 1)UnknownNCT05420545
What this trial is testing

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 36
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Early research (Phase 1)Study completedNCT00622674
What this trial is testing

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 37
Next Page